Cancer Progress by Cello Health

Defined Health has a deep knowledge base within and across all therapeutic categories. The focus of our work closely mirrors the therapeutic area focus of today’s biopharmaceutical pipeline.

* Keynote speaker:

Rachel Haurwitz, PhD, Chief Executive Officer, and Founder, Caribou

Tim van Hauwermeiren (arGEN-X), Yibin Kang (Princeton University), Brian Leyland-Jones (Avera Cancer Institute), Axel Hoos (GSK), Hapreet Singh (Immatics), John Haurum (f-Star), Ji Li (Lilly Asia Ventures), Weimin Tang (I-Mab Biopharma).

For More Information:





Defined Health’s Insight Series Webinar

Nov/Dec 2018

“Changing competitive landscape with the influx of China money and development”

Moderator: James Lee, PhD, Associate Principal, Oncology Lead, Defined Health

To register and to learn more about the webinar visit: